REX BERRY: Open Payments
NPI 1124787098 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 48 payments from 8 companies in 2025. Trend: 2023 $464 · 2024 $2,125 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $367 |
| Verona Pharma, Inc. | 8 | $184 |
| GlaxoSmithKline, LLC. | 15 | $155 |
| Actelion Pharmaceuticals US, Inc. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Vifor Pharma, Inc. | 1 | $25 |
| Grifols USA, LLC | 1 | $24 |
| United Therapeutics Corporation | 1 | $18 |
Products named: Ohtuvayre, NUCALA, FASENRA, BREZTRI, DUPIXENT, AIRSUPRA, TRELEGY ELLIPTA, Zemaira.
Industry payments across PA — which companies pay providers there.
